Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Urodynamic Testing Market, By Test Type (Uroflowmetry, Electromyography, Cystometric Test, Leak Point Pressure Measurement Test, Others), End User (Hospitals, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The Global Prevalence Infection in Urology (GPIU) study data revealed that about 10% of patients hospitalised in urological wards have a health care-linked infection, according to a report released by the European Association of Urology in 2013. The involuntary loss of pee as a result of losing bladder control is known as urinary incontinence. Urinary incontinence, which affects an estimated 500 million individuals worldwide, is one of the key drivers propelling the global market for urodynamic testing.
Data Bridge Market Research analyses that the urodynamic testing market which was USD 337.34 million in 2021, would rocket up to USD 643.13 million by 2029, and is expected to undergo a CAGR of 8.4% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Test Type (Uroflowmetry, Electromyography, Cystometric Test, Leak Point Pressure Measurement Test, Others), End User (Hospitals, Diagnostic Laboratories, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
|
|
Market Opportunities |
Increasing incidence of urological dysfunctions Availability of advanced and safe urodynamic products in the marketplace |
Market Definition
Urodynamic testing may determine how well the bladder works. The test aids in determining the causes of urine leakage, obstruction in the bladder, or the urine's flow channel. Numerous conditions can cause urinary symptoms include frequent urination, urgency when urinating, painful urination, recurrent urinary tract infections, poor urine flow, and incontinence. The precise cause of the problem can be identified with the aid of an urodynamic test.
Urodynamic Testing Market Dynamics
Drivers
- Increasing prevalence of diseases
Over the forecast period of 2022 to 2029, the prevalence of disorders such bladder cancer, benign prostatic hypertrophy, neurogenic bladder dysfunction, and overactive bladder will likely continue to rise, which will likely drive the urodynamic testing market. Additionally, it is anticipated that the increased prevalence of urinary system issues brought on by pregnancy, injuries, ageing, and other factors that necessitate urine testing to start treatment will advance the market growth for urodynamic testing.
- Increasing in urological disorders
The increase in urological disorders and the quick expansion of healthcare programmes to raise awareness of urological issues are both factors in the expansion of the target market. The incidence of bladder infections, rising rates of target diseases, rising disposable income globally, and an ageing population are all factors driving up demand for urodynamic testing.
- Raise awareness of urological issues
The target market is expanding due to increased efforts being made to raise awareness of urological issues and the accessibility of urological disorder therapy and diagnostics. Additionally, during the aforementioned forecast period, the market for urodynamic testing will benefit from numerous growth opportunities due to ongoing product approvals, an expanding network of testing facilities, and the simple availability of medical reimbursement for urological preliminary tests.
Opportunities
- Increase in the number of research and development activities
The market growth is fuelled by an expanding network of testing facilities, and the simple availability of medical reimbursement for urological preliminary tests. This will provide beneficial opportunities for the market growth.
Restraints/Challenges
The high costs associated with development of new drug entity and distribution, will slow the market's growth rate. The market will be hampered by a lack of awareness about this testing. The presence of substitutes will pose a challenge to market growth during the forecast period.
This urodynamic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urodynamic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Urodynamic Testing Market
The COVID-19 epidemic has slightly influenced healthcare systems and the market. The COVID-19 pandemic's effects on urology practise in the United States and insights into the changes in health care delivery that have been noticed in this multimodal medical specialty. While the number of clinical visits fluctuated initially between increases and decreases, the number of surgical procedures decreased across the study period, and the use of several diagnostic techniques stayed below baseline, potentially influencing patient outcomes in the future. To assess the short- and long-term effects of the COVID-19 pandemic on health care delivery in the United States, new data sources in other specialties as well as the AQUA Registry are necessary.
Recent Development
- In April 2019 –Boston Scientific Corporation announces a four year exclusive marketing agreement with Bladder Health Network.
Global Urodynamic Testing Market Scope
The urodynamic testing market is segmented on the basis of test type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Uroflowmetry
- Electromyography
- Cystometric Test
- Leak Point Pressure Measurement Test
- Others
End User
- Hospitals
- Diagnostic Laboratories
- Others
Urodynamic Testing Market Regional Analysis/Insights
The urodynamic testing market is analysed and market size insights and trends are provided by country, test type, and end-user as referenced above.
The countries covered in the urodynamic testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the urodynamic testing market owing to the ever-increasing prevalence of urinary incontinence in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increased awareness about urinary diseases and their effects in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Urodynamic Testing Market Share Analysis
The urodynamic testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urodynamic testing market.
Some of the major players operating in the urodynamic testing market are:
- Laboratory Corporation of America Holdings (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Accu Reference Medical Labs (U.S.)
- Eurofins Scientific (Luxembourg)
- Urology Specialists (U.S.)
- Arkansas Urology (U.S.)
- Mayo Foundation (U.S.)
- Medtronic (Ireland)
- BD (U.S.)
- Albyn Medical S.L. (Spain)
- Boston Scientific Corporation (U.S.)
- Coopersurgical, Inc. (U.S.)
- LABORIE (U.S.)
- Verathon, Inc. (U.S.)
- Medica SpA (Italy)
- Neomedix Systems Pty. Ltd. (Australia)
- DANTEC DYNAMICS LTD (Denmark)
SKU-
